logo-loader
RNS
Frontier IP Group PLC

Frontier IP Group - Portfolio news – Pulsiv Solar awarded patent

RNS Number : 6489J
Frontier IP Group plc
15 April 2020
 

RNS REACH

AIM: FIPP

15 April 2020

 

Frontier IP Group plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Pulsiv Solar awarded Japanese patent and demonstrates strong progress on improving energy efficiency of battery chargers

 

 

Frontier IP, a specialist in commercialising intellectual property, today announces that portfolio company Pulsiv Solar Limited ("Pulsiv" or the "Company") has been granted a patent in Japan, further strengthening its intellectual property position.

 

The University of Plymouth spin out has also successfully integrated its technology into a standard battery charger, used by a host of devices such as power tools, significantly improving its energy efficiency and attracting strong interest from potential industry partners.   

 

In laboratory conditions, Pulsiv improved the power factor of the charger to over 90 per cent, and reduced the heat generated by the charger. The Pulsiv circuit board comfortably fits into the same form factor as the standard battery charger circuit board. The Company has already demonstrated applications of the technology to improve the energy efficiency of photovoltaic solar cells and power converters used in many everyday devices, such as computers and televisions.

 

The Japanese patent award is the 13th granted globally for the Company's technology. Others have been awarded in the United States, Europe, China, Taiwan, Australia and Mexico. A further patent is proceeding to grant in China

 

Robert Bosch Limited, a subsidiary of Robert Bosch GmbH, has been working with Pulsiv to optimise the design of the Company's energy-efficient solar micro inverter prototype. When the prototype moves into full-scale commercial production, it will allow Pulsiv to market micro-inverters as "Engineered by Bosch".

 

The patents granted include those covering both the power conversion and solar microinverter technologies.

 

The Company has also received a £129,929 grant from Innovate UK, the UK's Innovation agency.

 

Frontier IP holds an 18.9 per cent equity interest in Pulsiv.

 

Pulsiv Solar technical director Dr Zaki Ahmed said: "We're delighted to be granted a patent in Japan. We are making strong progress, and are very excited about the potential for our technology in the type of battery charger used by millions of devices every day."

 

Frontier IP chief executive officer Neil Crabb said: "Pulsiv continues to go from strength to strength. Its success in integrating its technology into a standard battery charger used by devices such as power tools worldwide is a further demonstration of the Company's enormous potential."

 

ENQUIRIES

 

Frontier IP Group plc

T: 020-7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

T: 0203 328 5656

Nick Athanas / Nicholas Chambers 

 


ABout frontier IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

Frontier IP is the commercialisation partner for the University of Plymouth.

ABOUT THE UNIVERSITY OF PLYMOUTH

 

The University of Plymouth is renowned for high quality, internationally-leading education, research and innovation.

 

With a mission to Advance Knowledge and Transform Lives, Plymouth is a *top 50 research university with clusters of world class research across a wide range of disciplines including marine science and engineering, medicine, robotics and psychology. A three-time winner of the Queen's Anniversary Prize for Higher and Further Education, the University of Plymouth continues to grow in stature and reputation.

 

It has a strong track record for teaching and learning excellence and has one of the highest numbers of National Teaching Fellows of any UK university. With over 19,000 students, and a further 9,500 studying for a Plymouth degree at partner institutions in the UK and around the world, and over 130,000 alumni pursuing their chosen careers globally, it has a growing global presence.

http://www.plymouth.ac.uk

* Research Fortnight Research Power League Table 2014.

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain.   Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAKKQBKCBKDKQD
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

Frontier IP focused on further industrial engagement across portfolio

Neil Crabb, chief executive of Frontier IP Group Plc (LON:FIPP) caught up with Proactive's Andrew Scott following the release of their half-year report. Frontier’s portfolio includes AI drug researcher Exscientia which secured a €15mln strategic investment from drug discovery company...

on 29/3/18

4 min read